Daiken Investment Australia Pty Ltd, subsidiary of Daiken Biomed, Announces Intention to Acquire Australian Real Estate
Daiken Investment Australia Pty Ltd, a subsidiary of Daiken Biomed (Taiwan), plans to acquire the Ho… · 2026-06-08
大研生醫* News Releases
Why adjust Da Yan Biomed dividend rate?
After buying back 4.46M shares, Da Yan Biomed raised per‑share cash payout to NT$0.8934. · 2026-06-04
Dahyan Biotech Announces Shareholder Meeting Resolutions
Meeting on 115/06/04 approved profit allocation and lifted director non‑compete. · 2026-06-04
Daren Biotech Lifts Director Non-Compete Ban
June 4, Daren Biotech removed Lin Zhiming’s ban, permitting competition with no impact. · 2026-06-04
[Taiyen Bio-Tech] Announcement on Q4 114 Cash Dividend and Capital Surplus Cash Distribution Record Date
Taiyen Bio-Tech has announced its Q4 114 cash dividend and capital surplus cash distribution. The to… · 2026-06-04
【Dayeh Biomedical】Report on the Completion of Share Buyback Period
Dayeh Biomedical executed a share buyback from March 31 to May 25, 115. Out of the planned 7.5 milli… · 2026-05-25
[DAIKEN BIOMEDICAL*] Revises "Share Repurchase and Transfer to Employees Regulations" as Instructed by Regulatory Authority
Daiken Biomedical International Co., Ltd. is revising its "Share Repurchase and Transfer to Employee… · 2026-05-07
Dahan Biomedical Announces Board Resolution on 2026 First Quarter Earnings Distribution and Cash Dividend
Dahan Biomedical announced a cash dividend distribution for the first quarter of 2026. This includes… · 2026-05-07
Dahan Biomedical Announces Board Resolution on 2026 First Quarter Earnings Distribution and Cash Dividend
Dahan Biomedical announced a cash dividend distribution for the first quarter of 2026. This includes… · 2026-05-07
【DaYan BioMedical*】The Company's Board of Directors Approved the Consolidated Financial Statements for Q1 2026
DaYan BioMedical's Board of Directors has approved the consolidated financial statements for the fir… · 2026-05-07
[DAIKEN BIOMEDICAL*] Revises "Share Repurchase and Transfer to Employees Regulations" as Instructed by Regulatory Authority
Daiken Biomedical International Co., Ltd. is revising its "Share Repurchase and Transfer to Employee… · 2026-05-07
【DaYan BioMedical*】The Company's Board of Directors Approved the Consolidated Financial Statements for Q1 2026
DaYan BioMedical's Board of Directors has approved the consolidated financial statements for the fir… · 2026-05-07
Dayan Biomedical* Reports May 2026 Revenue of NT$203 Million (Up +29.2% YoY)
Dayan Biomedical announced revenue of NT$203 million for May 2026, a 29.2% increase compared to the … · 2026-05-01
【OBI Pharma*】Announcement of the Date for the Board Meeting to Review the Company's Q1 2026 Financial Report
OBI Pharma announced that its board meeting to review the Q1 2026 financial report will be held on M… · 2026-04-29
【OBI Pharma*】Announcement of the Date for the Board Meeting to Review the Company's Q1 2026 Financial Report
OBI Pharma announced that its board meeting to review the Q1 2026 financial report will be held on M… · 2026-04-29
Dayun Bio-Medicine* - April 2026 Revenue: 172 Million (Year-on-Year Increase of +40.5%)
Dayun Bio-Medicine* announced April 2026 revenue of 171.84 million yuan, achieving a significant 40.… · 2026-04-01
Dayun Bio-Medicine* - April 2026 Revenue: 172 Million (Year-on-Year Increase of +40.5%)
Dayun Bio-Medicine* announced April 2026 revenue of 171.84 million yuan, achieving a significant 40.… · 2026-04-01
【Dayan Biotech*】March 2026 Monthly Revenue TWD 190 Million (YoY +40.9%)
Dayan Biotech* reported a monthly revenue of TWD 190 million for March 2026, marking a 40.9% year-on… · 2026-03-01
【Dayan Biotech*】March 2026 Monthly Revenue TWD 190 Million (YoY +40.9%)
Dayan Biotech* reported a monthly revenue of TWD 190 million for March 2026, marking a 40.9% year-on… · 2026-03-01
【Da-Yeh-Sheng-Yi*】February 2026 Revenue Reaches 136 Million (YoY +18.7%)
Da-Yeh-Sheng-Yi* announced its revenue for February 2026 was 136 million, an 18.7% increase compared… · 2026-02-01
【Da-Yeh-Sheng-Yi*】February 2026 Revenue Reaches 136 Million (YoY +18.7%)
Da-Yeh-Sheng-Yi* announced its revenue for February 2026 was 136 million, an 18.7% increase compared… · 2026-02-01